Get the latest tech news
FDA approves eye drops that fix near vision without glasses
The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months.
Vuity (pilocarpine hydrochloride 1.25%) is a dual-action eye drop that can improve near vision but may cause side effects like brow heaviness or rare vitreoretinal issues due to the ciliary muscle activation. Aceclidine, a pupil-selective miotic, works without significantly stimulating the focusing (ciliary) muscle, creating a pinhole effect – which improves near vision without adverse outcomes seen in Vuity. "This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and struggling with the inevitable age-related loss of their near vision," said VIZZ clinical investigator Marc Bloomenstein, from Schwartz Laser Eye Care Center in Scottsdale, Arizona.
Or read this on Hacker News
